Introduction
According to the sleep disorders classification, insomnia is characterized by the inability to initiate, maintain or consolidate sleep resulting in an impairment of diurnal performance and decrease quality of life. According to the World Health Organization (WHO), nearly 40% of the general population complains about insomnia symptomatology for more than two weeks and less than 6 months (acute insomnia), while 10% of the general population complains of insomnia symptomatology for more than 6 months (chronic insomnia).
Insomnia has multiple subtypes and multiple etiological factors. Regarding idiopathic insomnia, one of the subtypes, we have recently reported that nearly 50% of the patients diagnosed with this sleep disorder, actually show EEG abnormalities characterized by sharp-wave activity with phase inversion, spikes and sharp-wave activity in the left frontal and front-central area [1] .
Furthermore, neuronal hyper-excitability has been reported both in insomniac patients as well as in patients affected with EEG abnormalities. It has been suggested that epileptic-like activity is the result of excessive neuronal excitation as well as impairment of neuronal conductivity inhibition. Epileptic patients resistant to treatment show increased excitability in the motor cortex when compared to epileptic patients that respond adequately to treatment [2] . On the other hand, EEG recordings obtained from insomniac patients show an increase of beta and gamma activity during sleep onset and light sleep, suggesting neuronal hyper-excitability [3] . Moreover, using a Positron Emission Tomography (PET), Noftzinger reported an increase of global glucose consumption in insomniac patients during wake-sleep transition [4] .
On the other hand, Transcranial Magnetic Stimulation (TMS) is a new tool for noninvasive stimulation of the nervous system. In 1985, Barker et al. reported the use of TMS in the motor pathways using a single stimulus. However, it was introduced as a therapeutic tool only when TMS was able to deliver repetitive stimuli in 1993 by Houser et al.
Currently, TMS has been proposed as a therapeutic tool for several illnesses of the nervous system, such as depression [5] and others characterized mainly by neuronal hyper-excitabilit [6] , such as post-traumatic stress disorder [7] , obsessive compulsive disorder and schizophrenia, among others [8] . Previous reports have shown that TMS has therapeutic effects on insomnia in patients affected with post-traumatic stress disorders. Most patients reported a subjective improvement in sleep quality after a 10-day TMS treatment [9] .
In the present study, TMS was applied to patients diagnosed with insomnia associated to EEG abnormalities.
Methods
Ten adult patients (4 males: 6 females; age range 19 -35) were included in this study. All patients were diagnosed initially with idiopathic insomnia, and the presence of abnormal electroencephalographic activity during sleep was detected. All patients attended two polysomnographic recordings (PSGR), one before and one after TMS therapy. This study included recording electroencephalographic (EEG), electrooculography (EOG), electromyography (EMG) and electrocardiographic (EKG) activities, as well as respiratory variables (thoracic-abdominal exertion, nasal flow and oximetry). To record cortical activity, a conventional electroencephalographic set up, including 16 channels with bi-polar leads, was used. The sleep recordings were made at the Universidad Autónoma Metropolitana Sleep Disorders Clinic with a 32 channel Caldwell digital polygraph. Sleep recording interpretation was based on the Rechtschaffen and Kales manual [9] and its adequacies published in 2007 by the American Academy of Sleep Medicine [10] . All patients signed informed consent forms to participate in the study and their agreement to delay any kind of treatment or therapy to control their sleep disorder during TMS therapy. After the initial PSG recording, patients were submitted daily to 15 minutes (900 pulses) of slow (1 HZ) TMS for 10 days. TMS was delivered using a Magstim 2004 with an 8-shape stimulator. TMS was applied over the skull in the region were the EEG abnormalities were found (left frontal and front-central areas). Once TMS ended, a second PSG recording was done using the same montage as described above.
Results were analyzed using a student T test (before and after therapy) as well as a Chi square test for analysis of proportions.
This study was evaluated and approved by the bioethics committee of the ABC Medical Center.
Results
TMS induced significant improvement in most sleep parameters, especially in those affected in insomnia patients. Table 1 shows the sepolysomnographic parameters. As can be observed, sleep efficiency increased significantly, as well as total sleep time. In addition, sleep latency decreased, as well as total wake time (Figure 1) . The arousal index and awakenings showed a nonsignificant decrease. As mentioned before, all patients studied displayed EEG abnormalities in the initial EEG recording. After TMS, the frequency of EEG abnormalities decreased significantly (Figure 2) .
Regarding sleep architecture, no significant differences were found after TMS in the percentage of light sleep, slow wave sleep and REM sleep (Figure 3) .
Finally, REM sleep latency, which initially showed an abnormal increase, returned to the normally reported values after TMS treatment. However, this difference was not statistically significant (Figure 4) . 
Discussion
The results consistently showed that daily, 15 minutes of TMS applied for 10 days, improve sleep parameters in patients affected with insomnia associated to EEG abnormalities. Recently, our group reported that nearly 50% of patients diagnosed with idiopathic insomnia actually show EEG abnormalities. This study also described a clear association between EEG abnormality frequency and the severity of insomnia [1] .
In the present study, the improvement of sleep parameters coincides with a significant decrease of EEG abnormalities, suggesting that the effect of TMS on sleep is due to the inhibition of EEG abnormalities.
Regarding the findings in the PSG recording, it is important to highlight the fact that the increase of total sleep time is not due to the increase of only one sleep stage. All stages of sleep-light sleep, slow wave sleep and REM sleep-showed a proportional increase. This is a crucial difference with the current pharmacological treatment of insomnia. Most of these drugs increase total sleep time by increasing light sleep, resulting in low sleep quality, as well as in an increase in diurnal somnolence [11] [12] . Furthermore, TMS induced a normalization of REM sleep latency (mean 96 min) for this age group [13] .
TMS is a tool, the therapeutic applications of which are rapidly spreading [14] - [19] . TMS allows stimulation of the central nervous system in a harmless way, without the use of electrodes or any other device. TMS can be slow (<1 Hz) or fast (>5 Hz). Slow TMS has a suppressor effect while fast TMS induces activation [18] . Slow, repetitive TMS has been successfully used in neuropsychiatric diseases linked to neuronal hyper-excitability, such as obsessive compulsive disorder, post-traumatic stress disorder, schizophrenia, Tourette's syndrome, and multiple sclerosis, among others [20] - [22] . Insomnia, the presence of EEG abnormalities, has been reported as a neuronal hyper-excitability disease [23] - [25] .
Our results regarding TMS and sleep are consistent with those reported by Rosenberg et al., in patients suffering from insomnia associated to post-traumatic stress disorder [11] .
Whether TMS improves insomnia symptoms or causes the decrease of EEG abnormalities making better sleep, is a question that must be answered by new researchers. A positive relation between the severity of insomnia and the frequency of EEG abnormalities has previously been reported [1] .
